The relationship between collagen scaffold cross-linking agents and neutrophils in the foreign body reaction

Biomaterials

Volumn 31, Issue 35, 2010, Pages 9192-9201

  Ye, Qingsong ^a,b,c   Harmsen, Martin C ^a   van Luyn, Marja J A ^a   Bank, Ruud A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b SICHUAN UNIVERSITY   (China)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

Foreign body reaction; Giant cell formation; Interferon gamma; Matrix metalloproteinase; Neutrophils; Phagocytosis

Indexed keywords

FOREIGN BODY REACTIONS; GIANT CELLS; INTERFERON-GAMMA; MATRIX METALLOPROTEINASES; NEUTROPHILS; PHAGOCYTOSIS;

ALDEHYDES; ANTIBIOTICS; ANTIGEN-ANTIBODY REACTIONS; CELLULAR MANUFACTURING; COLLAGEN; CROSSLINKING; DEGRADATION; DISKS (MACHINE COMPONENTS); DISKS (STRUCTURAL COMPONENTS); GLYCOPROTEINS; SEEPAGE; SOIL MECHANICS;

MACROPHAGES;

GAMMA INTERFERON; GLUTARALDEHYDE; HEXAMETHYLENE DIISOCYANATE; INTERLEUKIN 13; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; COLLAGEN DEGRADATION; CROSS LINKING; DERMIS; FOREIGN BODY REACTION; GENE EXPRESSION; GIANT CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROENVIRONMENT; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; ZYMOGRAPHY;

ANIMALS; COLLAGEN; CROSS-LINKING REAGENTS; FOREIGN-BODY REACTION; GIANT CELLS; GLUTARAL; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-13; ISOCYANATES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHAGOCYTOSIS; SHEEP; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

MUS; OVIS ARIES;

EID: 77957960546     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.049     Document Type: Article

References (27)

1. Brown R.A., Phillips J.B. Cell responses to biomimetic protein scaffolds used in tissue repair and engineering. Int Rev Cytol 2007, 262:75-150.
2. Sachlos E., Czernuszka J.T. Making tissue engineering scaffolds work. Review on the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater 2003, 5:29-39.
3. Tai H., Mather M.L., Howard D., Wang W., White L.J., Crowe J.A., et al. Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing. Eur Cell Mater 2007, 14:64-77.
4. Choi Y.H., Stamm C., Hammer P.E., Kwaku K.F., Marler J.J., Jones M., et al. Cardiac conduction through engineered tissue. Am J Pathol 2006, 169:72-85.
5. Wahl D.A., Sachlos E., Liu C., Czernuszka J.T. Controlling the processing of collagen-hydroxyapatite scaffolds for bone tissue engineering. J Mater Sci Mater Med 2007, 18:201-209.
6. Leach J.K. Multifunctional cell-instructive materials for tissue regeneration. Regen Med 2006, 1:447-455.
7. Munirah S., Kim S.H., Ruszymah B.H., Khang G. The use of fibrin and poly(lactic-co-glycolic acid) hybrid scaffold for articular cartilage tissue engineering: an in vivo analysis. Eur Cell Mater 2008, 15:41-52.
8. Anderson J.M., Jones J.A. Phenotypic dichotomies in the foreign body reaction. Biomaterials 2007, 28:5114-5120.
9. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
10. Luttikhuizen D.T., Harmsen M.C., van Luyn M.J. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 2006, 12:1955-1970.
11. Luttikhuizen D.T., van Amerongen M.J., de Feijter P.C., Petersen A.H., Harmsen M.C., van Luyn M.J. The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials 2006, 27:5763-5770.
12. van Amerongen M.J., Harmsen M.C., Petersen A.H., Kors G., van Luyn M.J. The enzymatic degradation of scaffolds and their replacement by vascularized extracellular matrix in the murine myocardium. Biomaterials 2006, 27:2247-2257.
13. Kyriakides T.R., Foster M.J., Keeney G.E., Tsai A., Giachelli C.M., Clark-Lewis I., et al. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 2004, 165:2157-2166.
14. Khouw I.M., van Wachem P.B., Plantinga J.A., de Leij L.F., van Luyn M.J. Enzyme and cytokine effects on the impaired onset of the murine foreign-body reaction to dermal sheep collagen. J Biomed Mater Res 2001, 54:234-240.
15. Jones J.A., McNally A.K., Chang D.T., Qin L.A., Meyerson H., Colton E., et al. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 2008, 84:158-166.
16. Luttikhuizen D.T., Harmsen M.C., van Luyn M.J. Cytokine and chemokine dynamics differ between rats and mice after collagen implantation. J Tissue Eng Regen Med 2007, 1:398-405.
17. Ye Q., van Amerongen M.J., Sandham J.A., Bank R.A., van Luyn M.J., Harmsen M.C. Site-specific tissue inhibitor of metalloproteinase-1 governs the matrix metalloproteinases-dependent degradation of crosslinked collagen scaffolds and is correlated with interleukin-10. J Tissue Eng Regen Med 2010.
18. Khouw I.M., van Wachem P.B., Molema G., Plantinga J.A., de Leij L.F., van Luyn M.J. The foreign body reaction to a biodegradable biomaterial differs between rats and mice. J Biomed Mater Res 2000, 52:439-446.
19. van Wachem P.B., van Luyn M.J., Olde Damink L.H., Dijkstra P.J., Feijen J., Nieuwenhuis P. Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagen. J Biomed Mater Res 1994, 28:353-363.
20. Olde Damink L.H., Dijkstra P.J., van Luyn M.J., van Wachem P.B., Nieuwenhuis P., Feijen J. Changes in the mechanical properties of dermal sheep collagen during in vitro degradation. J Biomed Mater Res 1995, 29:139-147.
21. Kubota K. Innate IFN-gamma production by subsets of natural killer cells, natural killer T cells and gammadelta T cells in response to dying bacterial-infected macrophages. Scand J Immunol 2010, 71:199-209.
22. Shiomi H., Masuda A., Nishiumi S., Nishida M., Takagawa T., Shiomi Y., et al. Gamma Interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to citrobacter rodentium infection. Infect Immun 2010, 78:2653-2666.
23. Li L., Huang L., Sung S.S., Lobo P.I., Brown M.G., Gregg R.K., et al. NKT Cell Activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 2007, 178:5899-5911.
24. Denny M.F., Yalavarthi S., Zhao W., Thacker S.G., Anderson M., Sandy A.R., et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010, 184:3284-3297.
25. Ikeda T., Ikeda K., Sasaki K., Kawakami K., Hatake K., Kaji Y., et al. IL-13 as well as IL-4 induces monocytes/macrophages and a monoblastic cell line (UG3) to differentiate into multinucleated giant cells in the presence of M-CSF. Biochem Biophys Res Commun 1998, 253:265-272.
26. DeFife K.M., Jenney C.R., Colton E., Anderson J.M. Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion. J Histochem Cytochem 1999, 47:65-74.
27. DeFife K.M., Jenney C.R., McNally A.K., Colton E., Anderson J.M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 1997, 158:3385-3390.